Dergiler / Ebelik ve Sağlık Bilimleri Dergisi / 2026 / Volume: 8 Issue: 2

Developing The Menstrual Migraine Symptoms Scale

Ayhan Parmaksız(İSTANBUL SAĞLIK VE TEKNOLOJİ ÜNİVERSİTESİ)0000-0002-0335-2330
Sayfa
—
Yayın Tarihi
2025-07-13
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Conclusion: The study findings conclusively demonstrated the validity and reliability of the MMSS as a robust measurement tool specifically designed for assessing female individuals.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Objective: The objective of this study was to develop the Menstrual Migraine Symptoms Scale (MMSS).
📊
Temel Bulgular & Veri:Methods: The study utilized a robust methodological design with a sample size of 582 participants.
💡
Sonuç & Katkı:Conclusion: The study findings conclusively demonstrated the validity and reliability of the MMSS as a robust measurement tool specifically designed for assessing female individuals.
🔬Tür:Research Article
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Menstrual migraine · scale development · symptom

Özet

Objective: The objective of this study was to develop the Menstrual Migraine Symptoms Scale (MMSS). Methods: The study utilized a robust methodological design with a sample size of 582 participants. The data underwent a comprehensive analysis employing various statistical techniques, including item analysis, Exploratory Factor Analysis (EFA), Confirmatory Factor Analysis (CFA), Cronbach's alpha internal consistency coefficient, and the Intraclass Correlation Coefficient (ICC) for test-retest reliability. Results: The two sub-dimensions of the scale, consisting of 19 items, demonstrated excellent internal consistency, with Cronbach's alpha coefficients ranging from 0.932 to 0.970. Furthermore, the total scale exhibited a high level of internal consistency, with a Cronbach's alpha coefficient of 0.976. The item correlation values within the scale ranged from 0.741 to 0.921, indicating strong relationships between the items. Conclusion: The study findings conclusively demonstrated the validity and reliability of the MMSS as a robust measurement tool specifically designed for assessing female individuals.

Abstract

Objective: The objective of this study was to develop the Menstrual Migraine Symptoms Scale (MMSS). Methods: The study utilized a robust methodological design with a sample size of 582 participants. The data underwent a comprehensive analysis employing various statistical techniques, including item analysis, Exploratory Factor Analysis (EFA), Confirmatory Factor Analysis (CFA), Cronbach's alpha internal consistency coefficient, and the Intraclass Correlation Coefficient (ICC) for test-retest reliability. Results: The two sub-dimensions of the scale, consisting of 19 items, demonstrated excellent internal consistency, with Cronbach's alpha coefficients ranging from 0.932 to 0.970. Furthermore, the total scale exhibited a high level of internal consistency, with a Cronbach's alpha coefficient of 0.976. The item correlation values within the scale ranged from 0.741 to 0.921, indicating strong relationships between the items. Conclusion: The study findings conclusively demonstrated the validity and reliability of the MMSS as a robust measurement tool specifically designed for assessing female individuals.

🔖

Bu Makaleye Atıf Yap

Güvener, Y. Ö., Erdoğan, M., Parmaksız, A. (2025). Developing The Menstrual Migraine Symptoms Scale. Ebelik ve Sağlık Bilimleri Dergisi, Volume: 8 Issue: 2. https://doi.org/10.62425/esbder.1556173

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (39)

  1. Ahmad, S. R., & Rosendale, N. (2022). Sex and gender considerations in episodic migraine. Current Pain and Headache Reports, 26(7), 505–516.
  2. Albarqi, M., Aldablan, M., Albahr, A., Alamer, M., Alnaim, A., Alnaim, A., & Almaqhawi, A. (2022). Prevalence, frequency, and disability of migraine headaches and tension headaches among the general population in the Eastern Region of Saudi Arabia. Journal of Medicine and Life, 15(11), 1371–1378.
  3. Allais, G., Chiarle, G., Sinigaglia, S., & Benedetto, C. (2018). Menstrual migraine: A review of current and developing pharmacotherapies for women. Expert Opinion on Pharmacotherapy, 19(2), 123–136.
  4. Alpar, R. (2018). Uygulamalı istatistik ve geçerlik‐güvenirlik: Spor, sağlık ve eğitim bilimlerinden örneklerle [Applied statistics and validity‐reliability with examples from sports health and education sciences]. Detay Publishing.
  5. Aslan, Ş. (2018). Sosyal bilimlerde araştırma yöntemleri [Research methods in social sciences]. Eğitim Yayınevi.
  6. Barus, J., Sudharta, H., & Adriani, D. (2023). Study of the mechanisms and therapeutic approaches of migraine in women and pregnancy: A literature review. Cureus, 15(2), e35284.
  7. Bektaş, H. (2017). Açımlayıcı faktör analizi [Exploratory factor analysis]. Beta Publishing.
  8. Boateng, G. O., Neilands, T. B., Frongillo, E. A., Melgar-Quiñonez, H. R., & Young, S. L. (2018). Best practices for developing and validating scales for health, social, and behavioral research: A primer. Frontiers in Public Health, 6, 149.
  9. Bryman, A., & Cramer, D. (2001). Quantitative data analysis with SPSS Release 10 for Windows: A guide for social scientists (1st ed.). Routledge.
  10. Brown, T. A. (2015). Confirmatory factor analysis for applied research (2nd ed.). Guilford Press.
  11. Burch, R., Rizzoli, P., & Loder, E. (2018). The prevalence and impact of migraine and severe headache in the United States: Figures and trends from government health studies. Headache, 58(4), 496–505.
  12. Chen, D., Willis-Parker, M., & Lundberg, G. P. (2020). Migraine headache: Is it only a neurological disorder? Links between migraine and cardiovascular disorders. Trends in Cardiovascular Medicine, 30(7), 424–430. DeVellis, R. F. (2016). Scale development: Theory and applications (4th ed.). Sage.
  13. Dixon, P. C., & Bergstrom, L. (2011). Menstrual migraine: Current strategies for diagnosis and management. The Journal for Nurse Practitioners, 7(6), 469–478.
  14. Doğan, İ., & Doğan, N. (2019). An overview evaluation of the content validity used in scale development studies. Turkiye Klinikleri Journal of Biostatistics, 11(2), 143–151.
  15. Erkorkmaz, Ü., Etikan, İ., Demir, O., Özdamar, K., & Sanisoğlu, S. Y. (2013). Confirmatory factor analysis and fit indices: Review. Turkiye Klinikleri Journal of Medical Sciences, 33(1), 210–223.
  16. Evci, N., & Aylar, F. (2017). Doğrulayıcı faktör analizinin ölçek geliştirme çalışmalarında kullanımı [The use of confirmatory factor analysis in scale development studies]. Sosyal Bilimler Dergisi, 389–412.
  17. Fabrigar, L. R., Wegener, D. T., MacCallum, R. C., & Strahan, E. J. (1999). Evaluating the use of exploratory factor analysis in psychological research. Psychological Methods, 4(3), 272–299.
  18. Headache Classification Committee of the International Headache Society (IHS). (2018). The international classification of headache disorders, 3rd edition. Cephalalgia, 38(1), 1–211.
  19. İlhan, M., & Çetin, B. (2014). Yapısal eşitlik modeli (YEM) analizlerinin Lisrel ve Amos programlarıyla gerçekleştirilmesi: Sonuçların karşılaştırılması [Comparison of the results of structural equation model (SEM) analyses performed using Lisrel and Amos programs]. Eğitimde ve Psikolojide Ölçme ve Değerlendirme Dergisi, 5(2).
  20. Kartal, M., & Bardakçı, S. (2018). SPSS ve AMOS ile uygulamalı güvenirlik ve geçerlilik analizleri [Reliability and validity analyses with SPSS and AMOS applied examples]. Akademisyen Kitabevi.
  21. Koo, T. K., & Li, M. Y. (2016). A guideline of selecting and reporting intraclass correlation coefficients for reliability research. Journal of Chiropractic Medicine, 15(2), 155–163.
  22. Kline, R. B. (2016). Principles and practice of structural equation modeling (4th ed.). Guilford Press. MacCallum, R. C., Widaman, K. F., Zhang, S., & Hong, S. (1999). Sample size in factor analysis. Psychological Methods, 4(1), 84–99. https://doi.org/10.1037/1082-989X.4.1.84
  23. Pavlović, J. M., Stewart, W. F., Bruce, C. A., Gorman, J. A., Sun, H., Buse, D. C., & Lipton, R. B. (2015). Burden of migraine related to menses: Results from the AMPP study. The Journal of Headache and Pain, 16(1).
  24. Polat, B., Özge, A., Yılmaz, N., Taşdelen, B., Düz, Ö., Kılı, S., & Sarı, S. (2020). Validity and reliability of the Turkish version of the Mig-SCog scale in migraine patients. Neurological Sciences and Neurophysiology, 37(1), 29.
  25. Polit, D., Beck, C., & Owen, S. (2007). Is the CVI an acceptable indicator of content validity? Appraisal and recommendations. Research in Nursing & Health, 30(4), 459–467.
  26. Saunders, K., Merikangas, K., Low, N. C., Von Korff, M., & Kessler, R. C. (2008). Impact of comorbidity on headache-related disability. Neurology, 70(7), 538–547.
  27. Seng, E. K., Martin, P. R., & Houle, T. T. (2022). Lifestyle factors and migraine. The Lancet Neurology, 21(10), 911–921.
  28. Steiner, T. J., Stovner, L. J., Jensen, R., Uluduz, D., & Katsarava, Z. (2020). Migraine remains second among the world’s causes of disability, and first among young women: Findings from GBD2019. The Journal of Headache and Pain, 21(1).
  29. Stovner, L. J., Nichols, E., Steiner, T. J., Abd-Allah, F., Abdelalim, A., Al-Raddadi, R. M., … Murray, C. J. L. (2018). Global, regional, and national burden of migraine and tension-type headache, 1990–2016: A systematic analysis for the Global Burden of Disease Study 2016. The Lancet Neurology, 17(11), 954–976.
  30. Tabachnick, B. G., & Fidell, L. S. (2019). Using multivariate statistics (7th ed.). Pearson.
  31. Tavakol, M., & Dennick, R. (2011). Making sense of Cronbach’s alpha. International Journal of Medical Education, 2, 53–55. https://doi.org/10.5116/ijme.4dfb.8dfd
  32. Tavşancıl, E. (2002). Tutumların ölçülmesi ve SPSS ile veri analizi [Measuring attitudes and data analysis with SPSS]. Nobel Yayıncılık.
  33. Vetvik, K. G., & MacGregor, E. A. (2017). Sex differences in the epidemiology, clinical features, and pathophysiology of migraine. The Lancet Neurology, 16(1), 76–87.
  34. Vetvik, K. G., & MacGregor, E. A. (2021). Menstrual migraine: A distinct disorder needing greater recognition. The Lancet Neurology, 20(4), 304–315.
  35. Wang, M., Zhu, G., Song, Z., & Kong, F. (2023). Clinical differences between menstrual migraine and nonmenstrual migraine: A systematic review and meta-analysis of observational studies. Journal of Neurology, 270(3), 1249–1265.
  36. Wu, Q., Wang, J., Lin, X., Han, D., Hu, H., & Gao, H. (2023). Determining the efficacy and safety of acupuncture for the preventive treatment of menstrual migraine: A protocol for a PRISMA-compliant systematic review and meta-analysis. Journal of Pain Research, 16, 101–109.
  37. Worthington, R. L., & Whittaker, T. A. (2006). Scale development research: A content analysis and recommendations for best practices. The Counseling Psychologist, 34(6), 806–838.
  38. Yang, M., Du, T., Long, H., Sun, M., Liang, F., & Lao, L. (2022). Acupuncture for menstrual migraine: A systematic review. BMJ Supportive & Palliative Care, 12(e6), e882–e892.
  39. Yeşilyurt, S., & Çapraz, C. (2018). Geliştirme çalışmalarında kullanılan kapsam geçerliği için bir yol haritası [A roadmap for content validity used in development studies]. Erzincan Üniversitesi Eğitim Fakültesi Dergisi, 20 (1), 251-264.